Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A placebo-controlled, multi-country & multi-center study to assess the efficacy, safety & immunogenicity of 2 doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy infants
Rotavirus Vaccine
444563/023
NCT00140673
Infections, Rotavirus
Phase 3
 
September 2013

Powered by ideaPoint, Inc.